Omni Bio Pharmaceutical Inc (OTCBB - OTC Pink Current Information:OMBP)

Data as of 3:59pm ET
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Company Description

Omni Bio Pharmaceutical, Inc. engages in the exploration of new methods of the use of plasma-derived alpha-1-antitrypsin (AAT), an FDA-approved drug that can be applied to the treatment of a range of inflammatory and immune diseases such as Type 1 diabetes. It also conducts research and development on recombinant forms of AAT. The company was founded on December 1, 2005 and is headquartered in Greenwood Village, CO.

Contact Information

Omni Bio Pharmaceutical, Inc.
5350 South Roslyn Street
Greenwood Village Colorado 80111
P:(303) 867-3415
Investor Relations:
(720) 488-4754



Individual stakeholders32.72%
Mutual fund holders--
Other institutional--

Top Executives

Bruce E. SchneiderChairman & Chief Executive Officer
Charles A. DinarelloChief Scientific Officer
Bruce D. ForrestChief Development Officer
Robert Cecil OgdenSecretary, Treasurer & Head-Investor Relations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.